NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Sponsor: University of California, San Francisco
Conditions: Depression, Anxiety Disorders
Interventions: SKY Breath Intervention
Countries: United States
Depression is highly debilitating and prevalent among adolescents. Adolescent-onset depression is associated with long, severe, and recurrent episodes that are often not responsive to treatment. There is a dire need to develop novel treatments that are efficient, cost-effective, and tolerant for this population. Sudarshan Kriya Yoga (SKY) is a breath-based meditative practice that entails a sequence of specific breathing techniques to help practitioners achieve a state of calm alertness. It has offered benefits as a therapeutic option for mild-to-moderate depression and anxiety disorders and as an adjunctive treatment in patients with major depressive disorder, but the neurological mechanism of SKY breath intervention is still not fully understood. The goal of this study is to determine the efficacy of SKY breath intervention in treating depressed adolescents and to understand its mechanisms. In this study, thirty depressed adolescents and thirty healthy controls will be recruited to evaluate the efficacy of the 8-week SKY intervention. Assessment for depression and anxiety, salivary cortisol, resting heart rate, blood pressure, and neuroimaging will be collected at the baseline, 4 weeks into SKY intervention (questionnaires only), and post-intervention. This will be the first study to evaluate the potential benefits of of SKY breath intervention as a treatment option for depressed adolescents.
Sex: ALL
Age: 16 Years to 24 Years
Healthy volunteers: Yes
Study type: OBSERVATIONAL
Inclusion Criteria: * adolescent participants ages 16-24 yrs old (NIH defines adolescents as up through age 24 years old) * mild-to-moderate depression with the BDI-II score greater than or equal to 14 (Smarr and Keefer 2011) * technologically able (Zoom); * nonpractitioners of daily meditation/breath-work. Exclusion Criteria: * pregnant or lactating females * metal implants unsafe for MRI * current or lifetime diagnosis of schizophrenia, schizoaffective, bipolar on lithium, or seizure disorders * recent surgical patient (within 6 months) * substance use disorder within the last 1 year * history of significant medical conditions (e.g. traumatic brain injury) * suicidal ideation (SI) with intent and/or plan to harm self (SI without intent and/or plan to harm self will be allowed to enter the study)
- San Francisco, California, United States